These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
715 related articles for article (PubMed ID: 24550281)
21. Epigenetic dysregulation of hematopoietic stem cells and preleukemic state. Kunimoto H; Nakajima H Int J Hematol; 2017 Jul; 106(1):34-44. PubMed ID: 28555413 [TBL] [Abstract][Full Text] [Related]
22. Genetic and epigenetic heterogeneity in acute myeloid leukemia. Li S; Mason CE; Melnick A Curr Opin Genet Dev; 2016 Feb; 36():100-6. PubMed ID: 27162099 [TBL] [Abstract][Full Text] [Related]
23. Dynamic changes in the clonal structure of MDS and AML in response to epigenetic therapy. Uy GL; Duncavage EJ; Chang GS; Jacoby MA; Miller CA; Shao J; Heath S; Elliott K; Reineck T; Fulton RS; Fronick CC; O'Laughlin M; Ganel L; Abboud CN; Cashen AF; DiPersio JF; Wilson RK; Link DC; Welch JS; Ley TJ; Graubert TA; Westervelt P; Walter MJ Leukemia; 2017 Apr; 31(4):872-881. PubMed ID: 27740633 [TBL] [Abstract][Full Text] [Related]
24. Retained functional normal and preleukemic HSCs at diagnosis are associated with good prognosis in DNMT3AmutNPM1mut AMLs. Donato E; Correia N; Andresen C; Karpova D; Würth R; Klein C; Sohn M; Przybylla A; Zeisberger P; Rothfelder K; Salih H; Bonig H; Stasik S; Röllig C; Dolnik A; Bullinger L; Buchholz F; Thiede C; Hübschmann D; Trumpp A Blood Adv; 2023 Mar; 7(6):1011-1018. PubMed ID: 36453648 [TBL] [Abstract][Full Text] [Related]
25. Mapping the cellular origin and early evolution of leukemia in Down syndrome. Wagenblast E; Araújo J; Gan OI; Cutting SK; Murison A; Krivdova G; Azkanaz M; McLeod JL; Smith SA; Gratton BA; Marhon SA; Gabra M; Medeiros JJF; Manteghi S; Chen J; Chan-Seng-Yue M; Garcia-Prat L; Salmena L; De Carvalho DD; Abelson S; Abdelhaleem M; Chong K; Roifman M; Shannon P; Wang JCY; Hitzler JK; Chitayat D; Dick JE; Lechman ER Science; 2021 Jul; 373(6551):. PubMed ID: 34244384 [TBL] [Abstract][Full Text] [Related]
26. Preleukemia: the normal side of cancer. Shlush LI; Minden MD Curr Opin Hematol; 2015 Mar; 22(2):77-84. PubMed ID: 25575035 [TBL] [Abstract][Full Text] [Related]
27. A comprehensive review of genetic alterations and molecular targeted therapies for the implementation of personalized medicine in acute myeloid leukemia. Kirtonia A; Pandya G; Sethi G; Pandey AK; Das BC; Garg M J Mol Med (Berl); 2020 Aug; 98(8):1069-1091. PubMed ID: 32620999 [TBL] [Abstract][Full Text] [Related]
28. The dark side of stemness - the role of hematopoietic stem cells in development of blood malignancies. Filipek-Gorzała J; Kwiecińska P; Szade A; Szade K Front Oncol; 2024; 14():1308709. PubMed ID: 38440231 [TBL] [Abstract][Full Text] [Related]
29. Clonal evolution of acute myeloid leukemia highlighted by latest genome sequencing studies. Zhang X; Lv D; Zhang Y; Liu Q; Li Z Oncotarget; 2016 Sep; 7(36):58586-58594. PubMed ID: 27474172 [TBL] [Abstract][Full Text] [Related]
30. MicroRNA-9 promotes proliferation of leukemia cells in adult CD34-positive acute myeloid leukemia with normal karyotype by downregulation of Hes1. Tian C; You MJ; Yu Y; Zhu L; Zheng G; Zhang Y Tumour Biol; 2016 Jun; 37(6):7461-71. PubMed ID: 26678889 [TBL] [Abstract][Full Text] [Related]
33. AML evolution from preleukemia to leukemia and relapse. Shlush LI; Mitchell A Best Pract Res Clin Haematol; 2015; 28(2-3):81-9. PubMed ID: 26590763 [TBL] [Abstract][Full Text] [Related]
34. Single-cell mutational profiling enhances the clinical evaluation of AML MRD. Ediriwickrema A; Aleshin A; Reiter JG; Corces MR; Köhnke T; Stafford M; Liedtke M; Medeiros BC; Majeti R Blood Adv; 2020 Mar; 4(5):943-952. PubMed ID: 32150611 [TBL] [Abstract][Full Text] [Related]
35. A hypothesis regarding the development of acute myeloid leukemia from preleukemic disorders. The role of protooncogenes. Preisler HD Cancer Genet Cytogenet; 1988 May; 32(1):133-42. PubMed ID: 3162703 [TBL] [Abstract][Full Text] [Related]
36. Clonal evolution of acute myeloid leukemia from diagnosis to relapse. Vosberg S; Greif PA Genes Chromosomes Cancer; 2019 Dec; 58(12):839-849. PubMed ID: 31478278 [TBL] [Abstract][Full Text] [Related]
37. Genetic hierarchy and temporal variegation in the clonal history of acute myeloid leukaemia. Hirsch P; Zhang Y; Tang R; Joulin V; Boutroux H; Pronier E; Moatti H; Flandrin P; Marzac C; Bories D; Fava F; Mokrani H; Betems A; Lorre F; Favier R; Féger F; Mohty M; Douay L; Legrand O; Bilhou-Nabera C; Louache F; Delhommeau F Nat Commun; 2016 Aug; 7():12475. PubMed ID: 27534895 [TBL] [Abstract][Full Text] [Related]
38. Minimal PU.1 reduction induces a preleukemic state and promotes development of acute myeloid leukemia. Will B; Vogler TO; Narayanagari S; Bartholdy B; Todorova TI; da Silva Ferreira M; Chen J; Yu Y; Mayer J; Barreyro L; Carvajal L; Neriah DB; Roth M; van Oers J; Schaetzlein S; McMahon C; Edelmann W; Verma A; Steidl U Nat Med; 2015 Oct; 21(10):1172-81. PubMed ID: 26343801 [TBL] [Abstract][Full Text] [Related]